BioCentury
ARTICLE | Company News

ImQuest Pharmaceuticals Inc., Duke University, Miriam Hospital at Brown University, National Institutes of Health, University of Pittsburgh, University of Utah

August 11, 2008 7:00 AM UTC

ImQuest received a five-year, $6.4 million award from NIH to develop a long-lasting topical microbicide to prevent HIV transmission. The company will work with the universities to develop ImQuest’s mi...